
Lavisetron 2mg Oral Drops
Marketer
Lavish Biotech
Salt Composition
Ondansetron (2mg)
Overview Lavisetron 2mg Oral Drops
PediaNausea 2mg oral solution is a medication for children experiencing nausea and vomiting. Its primary use is managing nausea and vomiting related to surgery, chemotherapy, radiation therapy, and gastrointestinal infections. It's also effective for vomiting induced by medications such as analgesics. Administer PediaNausea 2mg before or after meals. For chemotherapy-induced vomiting, give it 30 minutes beforehand. For radiation therapy, administer 1-2 hours prior, and 1 hour before surgery to prevent post-operative vomiting. If your child vomits the medication within 30 minutes, reassure them and repeat the dose. Avoid doubling the dose if it's nearing the next scheduled time. Temporary side effects, including headache, constipation, diarrhea, and fatigue, may occur but usually resolve with continued use. Contact your physician immediately if these persist or worsen. Disclose all medications your child is taking, including pain relievers, antibiotics, and antidepressants, as well as any history of liver or kidney issues, gastrointestinal obstructions, heart conditions, or medication/food allergies. This information is crucial for appropriate dosing and treatment planning.
Uses of Lavisetron 2mg Oral Drops
Managing nausea and vomiting
Major Benefits of Lavisetron 2mg Oral Drops:
Administer Lavisetron 2mg Oral Drops precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Always consult the product label for complete instructions before each use. Accurate measurement should be achieved using the provided calibrated dropper. While ingestion with or without food is permissible, consistent daily timing is preferable for optimal therapeutic effect.
Common Side effects of Lavisetron 2mg Oral Drops:
- Headache
- Constipation
- Diarrhea
- Fatigue
How to use Lavisetron 2mg Oral Drops:
Administer Lavisetron 2mg Oral Drops precisely as prescribed by your physician, adhering to both dosage and treatment duration. Always consult the product label for complete instructions prior to use. Accurate measurement should be achieved using the provided dropper. While consumption with or without food is acceptable, consistency is best achieved through regular, scheduled administration.
How Lavisetron 2mg Oral Drops works:
Prior to procedures like radiotherapy, chemotherapy, abdominal surgery, or other major operations, dying cells release serotonin into the bloodstream. This triggers the body's emetic centers, potentially causing nausea and vomiting in your child. Administering 2mg of Lavisetron Oral Drops pre-procedure effectively inhibits serotonin's action on these brain centers, thus preventing vomiting.
SAFETY ADVICE
AlcoholCAUTION
Using Lavisetron 2mg Oral Drops with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Pregnancy data on the use of 2mg Lavisetron oral drops is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Lavisetron 2mg oral drops while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Lavisetron 2mg Oral Drops on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Lavisetron 2mg Oral Drops without any required dosage modification.
LiverCAUTION
Patients with hepatic impairment should use Lavisetron 2mg oral drops cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Lavisetron 2mg Oral Drops :
Remain calm. Administer the forgotten dose upon recollection. Nevertheless, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose and adhere to the recommended dosage regimen.
Facts to Know About Lavisetron 2mg Oral Drops
| Label | Value |
|---|---|
| Chemical Category | Carbazole-based compound |
| Developing Habits | No. |
| Treatment Category | Digestive |
